Literature DB >> 17602087

Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.

Johan Hansson1, Mia Bergenmar, Per-Ake Hofer, Göran Lundell, Eva Månsson-Brahme, Ulrik Ringborg, Ingrid Synnerstad, Annika Ternesten Bratel, Ann-Marie Wennberg, Inger Rosdahl.   

Abstract

PURPOSE: To evaluate a program initiated in 1987 by the Swedish Melanoma Study Group aiming to provide preventive surveillance to kindreds with hereditary cutaneous melanoma and dysplastic nevus syndrome. PATIENTS AND METHODS: Overall, 2,080 individuals belonging to 280 melanoma families were followed for 14 years between 1987 and 2001 at 12 participating centers. Data were registered in a central database.
RESULTS: Among 1,912 skin lesions excised during follow-up, 41 melanomas were removed in 32 individuals. Of these, 15 (37%) were in situ melanomas and 26 (63%) invasive melanomas. The median tumor thickness of invasive melanomas was 0.5 mm. Ulceration was absent in 24 of 26 invasive melanomas (92%) and 12 (46%) lacked vertical growth phase. Compared with melanomas in the general Swedish population, the melanomas identified in these kindreds during follow-up had better prognostic characteristics. All melanomas except one were diagnosed in families with two or more first-degree relatives with melanoma. Diagnosis of melanoma occurred in three of eight kindreds with germline CDKN2A mutations, supporting that families with such mutations are at increased risk for melanoma development. Of the 32 individuals who developed melanoma during follow-up, 21 (66%) had had at least one previously diagnosed melanoma.
CONCLUSION: This study shows that a coordinated program aimed at detecting and offering skin surveillance in kindreds with hereditary cutaneous melanoma results in a low incidence of melanomas during the follow-up period and that the tumors that do arise have favorable prognostic characteristics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17602087     DOI: 10.1200/JCO.2007.11.4108

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  7 in total

1.  [Dermatology seminar Derma Update: extensive CME in 2 days].

Authors:  U Ayazpoor
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

Review 2.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

3.  Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.

Authors:  Jasper I van der Rhee; Femke A de Snoo; Hans F A Vasen; Wolter J Mooi; Hein Putter; Nelleke A Gruis; Nicole A Kukutsch; Wilma Bergman
Journal:  J Am Acad Dermatol       Date:  2011-05-12       Impact factor: 11.527

4.  The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of CDKN2A and CDK4.

Authors:  Alisa M Goldstein; Margaret A Tucker; Michael R Sargen; Ruth M Pfeiffer; David E Elder; Xiaohong R Yang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04       Impact factor: 4.090

5.  Phenocopies in melanoma-prone families with germ-line CDKN2A mutations.

Authors:  Hildur Helgadottir; Håkan Olsson; Margaret A Tucker; Xiaohong R Yang; Veronica Höiom; Alisa M Goldstein
Journal:  Genet Med       Date:  2017-12-07       Impact factor: 8.822

6.  Management of melanoma families.

Authors:  Wilma Bergman; Nelleke A Gruis
Journal:  Cancers (Basel)       Date:  2010-04-16       Impact factor: 6.639

7.  High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.

Authors:  Hildur Helgadottir; Veronica Höiom; Göran Jönsson; Rainer Tuominen; Christian Ingvar; Ake Borg; Håkan Olsson; Johan Hansson
Journal:  J Med Genet       Date:  2014-06-16       Impact factor: 6.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.